Maravai Lifesciences Holdings Inc (MRVI)
Cost of Revenue
$30.79M
Quarterly · Period ending: · USD
MRVI Cost of Revenue
Latest reported$30.79Mperiod ending
Latest reported$30.79Mperiod ending
MRVI Quarterly Cost of Revenue ($17.83M → $30.79M)
Quarterly cost of revenue
High-resolution chart · PNG
MRVI cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 30,792,000 | |
| 32,136,000 | |
| 37,624,000 | |
| 35,975,000 | |
| 39,629,000 | |
| 39,125,000 | |
| 37,444,000 | |
| 36,826,000 | |
| 38,271,000 | |
| 38,335,000 | |
| 35,108,000 | |
| 36,686,000 | |
| 43,273,000 | |
| 33,676,000 | |
| 53,253,000 | |
| 38,176,000 | |
| 37,496,000 | |
| 40,032,000 | |
| 40,633,000 | |
| 32,221,000 | |
| 37,811,000 | |
| 31,391,000 | |
| 23,395,000 | |
| 19,760,000 | |
| 21,197,000 | |
| 15,297,000 | |
| 17,830,000 |